Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001213900-25-014283
Filing Date
2025-02-14
Accepted
2025-02-14 16:20:17
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 11527
  Complete submission text file 0001213900-25-014283.txt   13228
Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Onconetix, Inc. (Subject) CIK: 0001782107 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-93586 | Film No.: 25629233
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ONCONETIX, INC. 201 E. FIFTH STREET, SUITE 1900 CINCINNATI OH 45202
Business Address
Schiess Ralph (Filed by) CIK: 0002006201 (see all company filings)

Type: SCHEDULE 13D/A